PP
ELV icon

Prospector Partners’s Elevance Health ELV Stock Holding History

Prospector Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100,500
Closed -$12M – 166
2014
Q3 		$12M Sell
100,500
-22,600
-18% -$2.59M 0.66% 53
2014
Q2 		$13.2M Sell
123,100
-38,600
-24% -$3.98M 0.63% 57
2014
Q1 		$16.1M Sell
161,700
-8,800
-5% -$796K 0.77% 49
2013
Q4 		$15.8M Sell
170,500
-11,000
-6% -$977K 0.7% 56
2013
Q3 		$15.2M Sell
181,500
-45,500
-20% -$3.9M 0.69% 52
2013
Q2 		$18.6M Buy
+227,000
New +$17M 0.92% 36

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Prospector Partners's ELV Position: Q4 2014 in Review

Prospector Partners sold out of Elevance Health (ELV) in Q4 2014, closing a stake of 100,500 shares — an estimated $12M sold.

Prospector Partners first reported a position in ELV in Q2 2013 and held it in 6 quarters. The position peaked at $18.6M in Q2 2013. 721 funds tracked by Wall St. Rank hold ELV as of Q4 2014.

  • Prospector Partners reported no remaining Elevance Health position as of Q4 2014 after selling out during the quarter.
  • Prospector Partners sold 100,500 Elevance Health shares in Q4 2014, an estimated $12M.
  • Prospector Partners first reported a position in Elevance Health in Q2 2013 and held it in 6 quarters.
  • Prospector Partners's Elevance Health position peaked at $18.6M in Q2 2013.
  • 721 funds tracked by Wall St. Rank held Elevance Health as of Q4 2014.

Based on Prospector Partners's 13F filing for Q4 2014, filed 13 Feb 2015.